Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations

Nov 6, 2022

Home » Publications » Published 2022 Girard N, Wolf J, Kron A, Scheffler M, Knott CS Bosquet L et al. Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating epidermal growth factor...

Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England

Sep 9, 2022

Home » Publications » Published 2022 Kearney M, Knott CS, Mahmoudpour H, Verpillat P. Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England. ESMO 2022; 2022 Sept...

Evolution of the treatment landscape in patients with advanced or metastatic cancers following the approval of immuno-oncology treatments

Aug 24, 2022

Home » Publications » Published 2022 Mahmoudpour H, Knott CS, Amin A, Boutmy E, Verpillat P. Evolution of the treatment landscape in patients with advanced or metastatic cancers following the approval of immuno-oncology treatments: analysis of the England National...

Comparison of survival outcomes between dostarlimab and comparator treatments (tx) in patients (pts) with advanced/recurrent (A/R) endometrial cancer (EC) in England

Jun 3, 2022

Home » Publications » Published 2022 Goulden S, Heffernan K, Nikitas FS, Shukla U, Knott CS, Hunger M, Pahwa A, Schade R. Comparison of survival outcomes between dostarlimab and comparator treatments (tx) in patients (pts) with advanced/recurrent (A/R) endometrial...

Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.

Dec 19, 2022

Home » Publications » Published 2022 Clements K, Dodwell D, Hilton B, Stevens-Harris I, Pinder S, Wallis MG, et al.BMJ Open 2022;12: e061585. http://dx.doi.org/10.1136/bmjopen-2022-061585corr1 Abstract: ​Purpose The introduction of breast screening in the UK led to an...

Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England

Oct 20, 2022

Home » Publications » Published 2022 Angela Whittle, Betina Blak, Amy Zalin-Miller, Orlaith Condon (2022) ‘Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England’; abstract accepted at the European...